Literature DB >> 11325848

Metastasis-associated differences in gene expression in a murine model of osteosarcoma.

C Khanna1, J Khan, P Nguyen, J Prehn, J Caylor, C Yeung, J Trepel, P Meltzer, L Helman.   

Abstract

Despite advances in the management of osteosarcoma (OSA) and other solid tumors, the development of metastasis continues to be the most significant problem and cause of death for cancer patients. To define genetic determinants of pulmonary metastasis, we have applied cDNA microarrays to a recently described murine model of OSA that is characterized by orthotopic tumor growth, a period of minimal residual disease, spontaneous pulmonary metastasis, and cell line variants that differ in metastatic potential. Microarray analysis defined 53 genes (of 3166 unique cDNAs) that were differentially expressed between the primary tumors of the more aggressive (K7M2) and less aggressive (K12) OSA models. By review of the literature, these differentially expressed genes were assigned to six nonmutually exclusive metastasis-associated categories (proliferation and apoptosis, motility and cytoskeleton, invasion, immune surveillance, adherence, and angiogenesis). Functional studies to evaluate K7M2 and K12 for differences in each of these metastasis-associated processes revealed enhanced motility, adherence, and angiogenesis in the more aggressive K7M2 model. For this reason, 10 of the 53 differentially expressed genes that were assigned to the motility and cytoskeleton, adherence, and angiogenesis categories were considered as most likely to define differences in the metastatic behavior of the two models. Ezrin, a gene not described previously in OSA, with functions in motility, invasion, and adherence, was 3-fold overexpressed in K7M2 compared with K12 by microarray. Differential expression for RNA was confirmed by Northern analysis and for protein by immunostaining. Alterations in ezrin protein levels and concomitant cytoskeletal changes in our model confirmed predictions from the arrays. The potential relevance of ezrin in OSA was suggested by its expression in five of five human OSA cell lines. This work represents a rationale approach to the evaluation of microarray data and will be useful to identify genes that may be causally associated with metastasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11325848

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  108 in total

1.  Dysregulation of ezrin phosphorylation prevents metastasis and alters cellular metabolism in osteosarcoma.

Authors:  Ling Ren; Sung-Hyeok Hong; Qing-Rong Chen; Joseph Briggs; Jessica Cassavaugh; Satish Srinivasan; Michael M Lizardo; Arnulfo Mendoza; Ashley Y Xia; Narayan Avadhani; Javed Khan; Chand Khanna
Journal:  Cancer Res       Date:  2011-12-06       Impact factor: 12.701

Review 2.  Role of gene expression arrays in sarcomas.

Authors:  Keith M Skubitz; Amy P N Skubitz
Journal:  Curr Oncol Rep       Date:  2004-07       Impact factor: 5.075

Review 3.  Targeted therapy in bone and soft tissue sarcoma in children and adolescents.

Authors:  Patrick A Thompson; Murali Chintagumpala
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

4.  Modeling metastasis biology and therapy in real time in the mouse lung.

Authors:  Arnulfo Mendoza; Sung-Hyeok Hong; Tanasa Osborne; Mohammed A Khan; Kirk Campbell; Joseph Briggs; Ananth Eleswarapu; Lauren Buquo; Ling Ren; Stephen M Hewitt; El Habib Dakir; El-H Dakir; Susan Garfield; Renard Walker; Glenn Merlino; Jeffrey E Green; Kent W Hunter; Lalage M Wakefield; Chand Khanna
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

5.  Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.

Authors:  Mikell Paige; George Kosturko; Güllay Bulut; Matthew Miessau; Said Rahim; Jeffrey A Toretsky; Milton L Brown; Aykut Üren
Journal:  Bioorg Med Chem       Date:  2013-11-14       Impact factor: 3.641

6.  Expression and significance of RhoC gene in hepatocellular carcinoma.

Authors:  Wei Wang; Lian-Yue Yang; Zhi-Li Yang; Gen-Wen Huang; Wei-Qun Lu
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

7.  Inhibition of AP-1 transcriptional activity blocks the migration, invasion, and experimental metastasis of murine osteosarcoma.

Authors:  Virna D Leaner; Jeffrey F Chick; Howard Donninger; Ilona Linniola; Arnulfo Mendoza; Chand Khanna; Michael J Birrer
Journal:  Am J Pathol       Date:  2008-12-12       Impact factor: 4.307

Review 8.  Gene expression studies of osteoporosis: implications for microarray research.

Authors:  V Dvornyk; R R Recker; H-W Deng
Journal:  Osteoporos Int       Date:  2003-04-29       Impact factor: 4.507

9.  Minnelide reduces tumor burden in preclinical models of osteosarcoma.

Authors:  Sulagna Banerjee; Venugopal Thayanithy; Veena Sangwan; Tiffany N Mackenzie; Ashok K Saluja; Subbaya Subramanian
Journal:  Cancer Lett       Date:  2013-03-14       Impact factor: 8.679

10.  Establishment and characterization of human osteosarcoma cell lines with different pulmonary metastatic potentials.

Authors:  Xiang Chen; Tong-Tao Yang; Wei Wang; Hong-Hui Sun; Bao-An Ma; Cun-Xiao Li; Qiong Ma; Zhe Yu; Qing-Yu Fan
Journal:  Cytotechnology       Date:  2009-11-29       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.